Outcomes before and after Implementation of the ERAS (Enhanced Recovery after Surgery) Protocol in Open and Laparoscopic Colorectal Surgery: A Comparative Real-World Study from Northern Italy.
Lucia MangoneFederica MereuMaurizio ZizzoAndrea MoriniMagda ZanelliFrancesco MarinelliIsabella BiscegliaMaria Barbara BraghiroliFortunato MorabitoAntonino NeriMassimiliano FabozziPublished in: Current oncology (Toronto, Ont.) (2024)
Enhanced Recovery After Surgery (ERAS) protocols have changed perioperative care, aiming to optimize patient outcomes. This study assesses ERAS implementation effects on postoperative complications, length of hospital stay (LOS), and mortality in colorectal cancer (CRC) patients. A retrospective real-world analysis was conducted on CRC patients undergoing surgery within a Northern Italian Cancer Registry. Outcomes including complications, re-surgeries, 30-day readmission, mortality, and LOS were assessed in 2023, the year of ERAS protocol adoption, and compared with data from 2022. A total of 158 surgeries were performed, 77 cases in 2022 and 81 in 2023. In 2023, a lower incidence of postoperative complications was observed compared to that in 2022 (17.3% vs. 22.1%), despite treating a higher proportion of patients with unfavorable prognoses. However, rates of reoperations and readmissions within 30 days post-surgery increased in 2023. Mortality within 30 days remained consistent between the two groups. Patients diagnosed in 2023 experienced a statistically significant reduction in LOS compared to those in 2022 (mean: 5 vs. 8.1 days). ERAS protocols in CRC surgery yield reduced postoperative complications and shorter hospital stays, even in complex cases. Our study emphasizes ERAS' role in enhancing surgical outcomes and recovery.
Keyphrases
- minimally invasive
- healthcare
- patients undergoing
- end stage renal disease
- risk factors
- ejection fraction
- primary care
- chronic kidney disease
- cardiovascular events
- newly diagnosed
- quality improvement
- coronary artery bypass
- prognostic factors
- squamous cell carcinoma
- cardiac surgery
- metabolic syndrome
- coronary artery disease
- insulin resistance
- surgical site infection
- pain management
- artificial intelligence
- health insurance
- patient reported outcomes